Latest Articles

  • In Reply: Pulmonary tuberculosis (January 2015)
    Catherine A. Curley, MD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 204; DOI: https://doi.org/10.3949/ccjm.82c.04004

    Readers comment on pheochromocytoma (November 2014) and pulmonary tuberculosis (January 2015).

  • The Surviving Sepsis Campaign: Where have we been and where are we going?
    R. Phillip Dellinger, MD, MSc, MCCM
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 237-244; DOI: https://doi.org/10.3949/ccjm.82gr.15001

    Evidence-based guidelines and performance-improvement practices will, it is hoped, reduce mortality from sepsis worldwide.

  • The art and science of clinical medicine and editorial policy
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 201-202; DOI: https://doi.org/10.3949/ccjm.82b.04015

    Most clinical decisions are made without any applicable data from clinical studies. This is the “art” of medicine.

  • Heart on the right may sometimes be ‘right’
    Prashant Sharma, MD, Vijaiganesh Nagarajan, MD, MRCP and Donald A. Underwood, MD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 206-208; DOI: https://doi.org/10.3949/ccjm.81a.13163

    When a 76-year-old man presented with right-sided chest pain, his ECG suggested dextrocardia.

  • Reviewers 2014
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 161;
  • Pneumatosis cystoides intestinalis: Is surgery always indicated?
    Dayakar Kancherla, MD, Swapna Vattikuti, MD and Kishore Vipperla, MD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 151-152; DOI: https://doi.org/10.3949/ccjm.82a.14006

    This disease is usually benign, but evidence of necrosis or pneumoperitoneum warrants immediate surgery.

  • Diabetes therapy and cardiac risk (November 2014)
    David Bell, MB
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 140; DOI: https://doi.org/10.3949/ccjm.82c.03001

    A reader comments on diabetes therapy and cardiac risk (November 2013).

  • Outcome measures need context
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 138-139; DOI: https://doi.org/10.3949/ccjm.82b.03015

    The patient in front of me may differ from those seen in a clinical trial and may care about other outcome measures.

  • Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists?
    Subramanian Kannan, MD and Christian Nasr, MD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 142-144; DOI: https://doi.org/10.3949/ccjm.81a.13066

    The risk in humans is difficult to quantify, but low.

  • Managing aneurysmal subarachnoid hemorrhage: It takes a team
    Airton Leonardo de Oliveira Manoel, MD, David Turkel-Parrella, MD, Abhijit Duggal, MD, Amanda Murphy, MD, PhD, Victoria McCredie, MD, FRCPC and Thomas R. Marotta, MD, FRCPC
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 177-192; DOI: https://doi.org/10.3949/ccjm.82a.14021

    There is no silver bullet, but systematic application of small advances maximizes the patient’s chance of recovery.

Pages